These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Synthesis and analgesic properties of N-substituted trans-4a-aryldecahydroisoquinolines. Zimmerman DM; Cantrell BE; Swartzendruber JK; Jones ND; Mendelsohn LG; Leander JD; Nickander RC J Med Chem; 1988 Mar; 31(3):555-60. PubMed ID: 2831363 [TBL] [Abstract][Full Text] [Related]
12. Metopon and two unique derivatives: affinity and selectivity for the multiple opioid receptors. McLaughlin JP; Nowak D; Sebastian A; Schultz AG; Archer S; Bidlack JM Eur J Pharmacol; 1995 Dec; 294(1):201-6. PubMed ID: 8788432 [TBL] [Abstract][Full Text] [Related]
13. Highly selective kappa opioid analgesics. Synthesis and structure-activity relationships of novel N-[(2-aminocyclohexyl)aryl]acetamide and N-[(2-aminocyclohexyl)aryloxy]acetamide derivatives. Clark CR; Halfpenny PR; Hill RG; Horwell DC; Hughes J; Jarvis TC; Rees DC; Schofield D J Med Chem; 1988 Apr; 31(4):831-6. PubMed ID: 2832603 [TBL] [Abstract][Full Text] [Related]
14. Opioid agonist and antagonist bivalent ligands. The relationship between spacer length and selectivity at multiple opioid receptors. Portoghese PS; Larson DL; Sayre LM; Yim CB; Ronsisvalle G; Tam SW; Takemori AE J Med Chem; 1986 Oct; 29(10):1855-61. PubMed ID: 3020244 [TBL] [Abstract][Full Text] [Related]
15. Influence of spatial orientation of the C-6-OH group in ring C of morphine derivatives on opioid activity. Friedmann T; Tóth Z; Hosztafi S; Simon CS; Makleit S; Fürst S Arch Int Pharmacodyn Ther; 1994; 328(1):16-25. PubMed ID: 7893188 [TBL] [Abstract][Full Text] [Related]
16. MGM-9 [(E)-methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate], a derivative of the indole alkaloid mitragynine: a novel dual-acting mu- and kappa-opioid agonist with potent antinociceptive and weak rewarding effects in mice. Matsumoto K; Takayama H; Narita M; Nakamura A; Suzuki M; Suzuki T; Murayama T; Wongseripipatana S; Misawa K; Kitajima M; Tashima K; Horie S Neuropharmacology; 2008 Aug; 55(2):154-65. PubMed ID: 18550129 [TBL] [Abstract][Full Text] [Related]
17. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists. Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176 [TBL] [Abstract][Full Text] [Related]
18. Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone]. Ananthan S; Khare NK; Saini SK; Seitz LE; Bartlett JL; Davis P; Dersch CM; Porreca F; Rothman RB; Bilsky EJ J Med Chem; 2004 Mar; 47(6):1400-12. PubMed ID: 14998329 [TBL] [Abstract][Full Text] [Related]
19. Opioid agonist affinity in the guinea-pig ileum and mouse vas deferens. Porreca F; LoPresti D; Ward SJ Eur J Pharmacol; 1990 Apr; 179(1-2):129-39. PubMed ID: 2163849 [TBL] [Abstract][Full Text] [Related]
20. The mu, kappa and delta properties of various opioid agonists. Takemori AE; Ikeda M; Portoghese PS Eur J Pharmacol; 1986 Apr; 123(3):357-61. PubMed ID: 3013652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]